Get Started

INSM

NASD Insmed Incorporated
Oct 29, 2026 · 12:46 AM ET EOD Market Closed

$96.98 ↑ +0.00 (+0.00%) Trading Up from the previous close of $96.98, $0.94 below the day’s high of $97.92

YTD change
-44.28%
vs 20-day SMA
-2.83%
vs 200-day SMA
-23.21%

Price ranges

Previous day
$92.87 $96.37
open $93.33 close $94.96
+$1.63 (+1.75%)
Today
$93.86 $97.92
open $94.01 now $96.98
+$2.97 (+3.16%)
Past week
$92.63 $97.09
from $95.67 now $96.98
+$1.31 (+1.37%)
Past month
$92.63 $116.43
from $115.63 now $96.98
-$18.65 (-16.13%)
This year
$90.39 $186.19
from $174.04 now $96.98
-$77.06 (-44.28%)

Price & Performance

-37.96 (-28.13%) / 6M

$88.03$106.64$125.25$143.86Apr 28Jul 29Oct 28

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 54.4% away from all-time highs of $212.75
  • INSM is down 44% since the beginning of the year
  • INSM is down 41% over the past 12 months
  • INSM is down 16% over the past 1 month
  • 6% of all INSM investors are betting against INSM

INSM reads neutral: price sits below both the 20- and 200-day averages, the 12-month move is -41.3%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.06
Earnings momentum +84.5% Quarterly EPS growth
Quarterly change +84.5%

Valuation

P/E ratio N/A
Enterprise value $20.2B
Beta 1.46

Balance sheet & scale

IncomeN/A
Revenue$1.1B
Cash$1.2B
Debt$747.3K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $21.2B

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,288.30 +0.50%
JNJ Johnson & Johnson $271.04 +0.86%
ABBV AbbVie, Inc. $285.99 -0.14%
MRK Merck & Co., Inc. $140.93 -0.63%
RHHVF Roche Holding Ltd $487.52 +1.44%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.